Physician profile
Andrew Chen
NPI 1922390244
$4,273.61
in general payments reported to CMS, 2019-2025
11 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2021: $425 · 2022: $1,616 · 2023: $1,063 · 2024: $908 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,086.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,400.69 | 2021-2025 | Emblem Mri S-Icd, Bodyguardian, Accolade Sr |
| Vyaire Medical, INC. | $157.22 | 2022 | |
| Chiesi USA, INC. | $144.25 | 2021 | |
| Covidien LP | $132.86 | 2019 | |
| Heron Therapeutics, INC. | $125.00 | 2024 | Aponvie |
| Pacira Pharmaceuticals Incorporated | $119.04 | 2024 | Exparel |
| La Jolla Pharmaceutical Company | $107.92 | 2022 | |
| Merck Sharp & Dohme LLC | $29.20 | 2023 | Bridion |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.50 | 2024 | Lifevest |
| Solventum Corporation | $21.91 | 2025 | V.A.C. Veraflo Cleanse Choice, Abthera, Prevena |
| Baxter Healthcare | $13.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.